Moreover, we provide robust in vivo evidence demonstrating that targeting ALDH3A2, either through genistein treatment or gene overexpression, effectively inhibits GC cell proliferation, migration, and invasion, while suppressing tumor growth and metastasis by promoting ferroptosis. Here, ALDH3A2 is linked to gastric cancer.